• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Validated single-tube multiparameter flow cytometry approach for the assessment of minimal residual disease in multiple myeloma.

作者信息

Dold Sandra Maria, Riebl Veronika, Wider Dagmar, Follo Marie, Pantic Milena, Ihorst Gabriele, Duyster Justus, Zeiser Robert, Wäsch Ralph, Engelhardt Monika

机构信息

Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, Germany.

Clinical Trials Unit, Medical Center - University of Freiburg, Faculty of Medicine, Germany.

出版信息

Haematologica. 2020 Oct 1;105(10):e523. doi: 10.3324/haematol.2019.238394.

DOI:10.3324/haematol.2019.238394
PMID:33054097
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7556664/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd7e/7556664/c2734a324427/105e523.fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd7e/7556664/05d10c343466/105e523.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd7e/7556664/c2734a324427/105e523.fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd7e/7556664/05d10c343466/105e523.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd7e/7556664/c2734a324427/105e523.fig2.jpg

相似文献

1
Validated single-tube multiparameter flow cytometry approach for the assessment of minimal residual disease in multiple myeloma.用于评估多发性骨髓瘤微小残留病的经验证的单管多参数流式细胞术方法。
Haematologica. 2020 Oct 1;105(10):e523. doi: 10.3324/haematol.2019.238394.
2
Assessment of response to therapy in multiple myeloma by multiparameter flow cytometry. Usefulness of an eight-color single tube with monoclonal antibodies in dried formulation.通过多参数流式细胞术评估多发性骨髓瘤的治疗反应。含单克隆抗体的八色单管干燥制剂的实用性。
Clin Ter. 2019 Sep-Oct;170(5):e352-e356. doi: 10.7417/CT.2019.2159.
3
Minimal residual disease detection in multiple myeloma: comparison between BML single-tube 10-color multiparameter flow cytometry and EuroFlow multiparameter flow cytometry.多发性骨髓瘤微小残留病灶检测：BML 单管十色多参数流式细胞术与 EuroFlow 多参数流式细胞术的比较。
Ann Hematol. 2021 Dec;100(12):2989-2995. doi: 10.1007/s00277-021-04634-5. Epub 2021 Aug 25.
4
The prognostic value of multiparameter flow cytometry minimal residual disease assessment in relapsed multiple myeloma.多参数流式细胞术微小残留病评估在复发多发性骨髓瘤中的预后价值
Haematologica. 2015 Feb;100(2):e53-5. doi: 10.3324/haematol.2014.115162. Epub 2014 Nov 7.
5
An analysis of the false negative rate of minimal residual disease measurement by multiparameter flow cytometry in multiple myeloma.多参数流式细胞术检测多发性骨髓瘤微小残留病的假阴性率分析
Int J Lab Hematol. 2020 Apr;42(2):e65-e67. doi: 10.1111/ijlh.13112. Epub 2019 Sep 20.
6
Single-Tube 10-Fluorochrome Analysis for Efficient Flow Cytometric Evaluation of Minimal Residual Disease in Plasma Cell Myeloma.单管10荧光染料分析法用于浆细胞骨髓瘤微小残留病的高效流式细胞术评估
Am J Clin Pathol. 2016 Jul;146(1):41-9. doi: 10.1093/ajcp/aqw052.
7
A single-tube six-colour flow cytometry screening assay for the detection of minimal residual disease in myeloma.一种用于检测骨髓瘤微小残留病的单管六色流式细胞术筛查检测方法。
Leukemia. 2007 Sep;21(9):2046-9. doi: 10.1038/sj.leu.2404815. Epub 2007 Jul 26.
8
BrdU incorporation in multiparameter flow cytometry: A new cell cycle assessment approach in multiple myeloma.BrdU 掺入多参数流式细胞术：多发性骨髓瘤中一种新的细胞周期评估方法。
Cytometry B Clin Cytom. 2019 May;96(3):209-214. doi: 10.1002/cyto.b.21730. Epub 2018 Nov 12.
9
Comparison of cross-platform flow cytometry minimal residual disease evaluation in multiple myeloma using a common antibody combination and analysis strategy.使用共同抗体组合和分析策略对多发性骨髓瘤进行跨平台流式细胞术微小残留病评估的比较。
Cytometry B Clin Cytom. 2015 Mar;88(2):101-9. doi: 10.1002/cyto.b.21200. Epub 2014 Nov 17.
10
Comparison of minimal residual disease detection in multiple myeloma by SRL 8-color single-tube and EuroFlow 8-color 2-tube multiparameter flow cytometry.采用SRL 8色单管和EuroFlow 8色2管多参数流式细胞术检测多发性骨髓瘤微小残留病的比较
Int J Hematol. 2019 Apr;109(4):377-381. doi: 10.1007/s12185-019-02615-z. Epub 2019 Feb 18.

引用本文的文献

1
Flow Cytometric Analysis of Bone Marrow Particle Cells for Measuring Minimal Residual Disease in Multiple Myeloma.用于测量多发性骨髓瘤微小残留病的骨髓颗粒细胞的流式细胞术分析
Cancers (Basel). 2022 Oct 8;14(19):4937. doi: 10.3390/cancers14194937.
2
Harmonization of Flow Cytometric Minimal Residual Disease Assessment in Multiple Myeloma in Centers of Polish Myeloma Consortium.波兰骨髓瘤联盟各中心多发性骨髓瘤流式细胞术微小残留病评估的标准化
Diagnostics (Basel). 2021 Oct 11;11(10):1872. doi: 10.3390/diagnostics11101872.
3
Minimal Residual Disease in Multiple Myeloma: Something Old, Something New.
多发性骨髓瘤中的微小残留病：旧貌新颜。
Cancers (Basel). 2021 Aug 27;13(17):4332. doi: 10.3390/cancers13174332.
4
Choosing the Right Therapy for Patients with Relapsed/Refractory Multiple Myeloma (RRMM) in Consideration of Patient-, Disease- and Treatment-Related Factors.考虑患者、疾病和治疗相关因素，为复发/难治性多发性骨髓瘤（RRMM）患者选择合适的治疗方法。
Cancers (Basel). 2021 Aug 26;13(17):4320. doi: 10.3390/cancers13174320.
5
Ten Color Multiparameter Flow Cytometry in Bone Marrow and Apheresis Products for Assessment and Outcome Prediction in Multiple Myeloma Patients.用于评估和预测多发性骨髓瘤患者预后的骨髓及单采成分血十色多参数流式细胞术
Front Oncol. 2021 Aug 13;11:708231. doi: 10.3389/fonc.2021.708231. eCollection 2021.
6
Treatment of therapy-related acute myeloid leukemia and underlying multiple myeloma with decitabine/venetoclax and daratumumab.使用地西他滨/维奈克拉和达雷妥尤单抗治疗与治疗相关的急性髓系白血病及潜在的多发性骨髓瘤。
Ann Hematol. 2021 Jun;100(6):1637-1640. doi: 10.1007/s00277-021-04490-3. Epub 2021 Mar 13.